本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Pacira Pharmaceuticals

23.31
+0.41001.79%
盘后23.310.00000.00%16:05 EDT
成交量:69.47万
成交额:1,596.56万
市值:10.79亿
市盈率:-10.28
高:23.36
开:22.94
低:22.23
收:22.90
数据加载中...
2023/06/06

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/06/06

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/06/06

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/06/06

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/06/06

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/06/05

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/06/05

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/06/05

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/06/05

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/05/31

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/05/15

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/05/11

关联方拟减持公告

144 - Report of proposed sale of securities
2023/05/03

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2023/05/03

重要事件披露

8-K - Current report
2023/04/03

关联方拟减持公告

144 - Report of proposed sale of securities
2023/04/03

重要事件披露

8-K - Current report
2023/03/22

重要事件披露

8-K - Current report
2023/02/28

年度报告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2023/02/28

重要事件披露

8-K - Current report
2023/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals